Kelly J - Search Results

1

Molecular response to imatinib in chronic myeloid leukaemia with a variant e13a3 BCR-ABL1 fusion.

McCarron SL, Langabeer SE, Bolger K, Haslam K, Crampe M, Kelly J, Morrell R. McCarron SL, et al. Among authors: kelly j. Med Oncol. 2015 Feb;32(2):452. doi: 10.1007/s12032-014-0452-3. Epub 2015 Jan 13. Med Oncol. 2015. PMID: 25579165

2

Rapid Evolution to Blast Crisis Associated with a Q252H ABL1 Kinase Domain Mutation in e19a2 BCR-ABL1 Chronic Myeloid Leukaemia.

McCarron SL, Maher K, Kelly J, Ryan MF, Langabeer SE. McCarron SL, et al. Among authors: kelly j. Case Rep Hematol. 2013;2013:490740. doi: 10.1155/2013/490740. Epub 2013 Sep 16. Case Rep Hematol. 2013. PMID: 24109527 Free PMC article.

3

Characterization of a novel variant BCR-ABL1 fusion transcript in a patient with chronic myeloid leukemia: Implications for molecular monitoring.

Crampe M, Haslam K, Kelly J, Conneally E, Langabeer SE. Crampe M, et al. Among authors: kelly j. Hematol Oncol Stem Cell Ther. 2017 Jun;10(2):85-88. doi: 10.1016/j.hemonc.2016.02.002. Epub 2016 Mar 17. Hematol Oncol Stem Cell Ther. 2017. PMID: 27013275 Free article.

4

Chronic myeloid leukemia with a novel e8a1 BCR-ABL1 fusion: rapid molecular response with nilotinib.

Crampe M, Shakkak F, Kelly J, Hodgson A, Langabeer SE. Crampe M, et al. Among authors: kelly j. Leuk Lymphoma. 2017 Sep;58(9):1-6. doi: 10.1080/10428194.2017.1281413. Epub 2017 Jan 25. Leuk Lymphoma. 2017. PMID: 28121203 No abstract available.

5

Acute lymphoblastic leukaemia with an e1a3 BCR-ABL1 fusion.

Langabeer SE, Haslam K, Kelly J, Leahy M, Vandenberghe E. Langabeer SE, et al. Among authors: kelly j. Acta Haematol. 2011;126(4):214-5. doi: 10.1159/000330956. Epub 2011 Sep 16. Acta Haematol. 2011. PMID: 21934295 No abstract available.

6

Chronic Myeloid Leukemia with e19a2 BCR-ABL1 Transcripts and Marked Thrombocytosis: The Role of Molecular Monitoring.

Langabeer SE, McCarron SL, Kelly J, Krawczyk J, McPherson S, Perera K, Murphy PT. Langabeer SE, et al. Among authors: kelly j. Case Rep Hematol. 2012;2012:458716. doi: 10.1155/2012/458716. Epub 2012 Jul 2. Case Rep Hematol. 2012. PMID: 22937329 Free PMC article.

7

A novel, variant BCR-ABL1 transcript not detected by standard real-time quantitative PCR in a patient with chronic myeloid leukaemia.

McCarron SL, Haslam K, Kelly J, Duggan C, Langabeer SE. McCarron SL, et al. Among authors: kelly j. Int J Lab Hematol. 2012 Feb;34(1):e1-2. doi: 10.1111/j.1751-553X.2011.01346.x. Epub 2011 Jun 22. Int J Lab Hematol. 2012. PMID: 21692997 No abstract available.

8

Targeted next-generation sequencing identifies clinically relevant mutations in patients with chronic neutrophilic leukemia at diagnosis and blast crisis.

Langabeer SE, Haslam K, Kelly J, Quinn J, Morrell R, Conneally E. Langabeer SE, et al. Among authors: kelly j. Clin Transl Oncol. 2018 Mar;20(3):420-423. doi: 10.1007/s12094-017-1722-2. Epub 2017 Jul 31. Clin Transl Oncol. 2018. PMID: 28762112

9

Allogeneic Hematopoietic Stem Cell Transplantation for a BCR-FGFR1 Myeloproliferative Neoplasm Presenting as Acute Lymphoblastic Leukemia.

Haslam K, Langabeer SE, Kelly J, Coen N, O'Connell NM, Conneally E. Haslam K, et al. Among authors: kelly j. Case Rep Hematol. 2012;2012:620967. doi: 10.1155/2012/620967. Epub 2012 Oct 2. Case Rep Hematol. 2012. PMID: 23082258 Free PMC article.

10

Sustained clinical remission despite suboptimal molecular response to imatinib in e1a2 BCR-ABL chronic myeloid leukemia.

Langabeer SE, Crampe M, Haslam K, Kelly J, Cahill MR. Langabeer SE, et al. Among authors: kelly j. Leuk Res. 2010 Jul;34(7):e176-7. doi: 10.1016/j.leukres.2010.01.025. Epub 2010 Feb 12. Leuk Res. 2010. PMID: 20153526 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,564 results

Search Page